Prosensa
AcquiredLeiden, Netherlands · Founded 2002 · $51.0M raised
- Headquarters
- Leiden
- Employees
- 51–200
- Founded
- 2002
- Business Model
- B2B
- Website
- prosensa.eu
- Total Funding
- $51.0M
- Last Round
- $30.0M Series CJan 2012
- Rounds
- 2
- Acquired by
- BioMarin Pharmaceutical Inc.Nov 2014 · $680.0M
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Prosensa was a Leiden, Netherlands-based biopharmaceutical company focused on the discovery, development, and commercialization of RNA-modulating therapeutics for rare neuromuscular diseases, particularly Duchenne muscular dystrophy. Founded in 2002, the company went public before being acquired by BioMarin Pharmaceutical in 2014 for approximately $680 million.
Summary
Prosensa is a Biotech company based in Leiden, Netherlands, founded in 2002. It has raised $51.0M in total across 2 rounds, most recently a $30.0M Series C round in Jan 2012. Investors include J.P. Morgan, Citi Ventures and SVB Leerink.
Funding & Exit History
Nov 2014
Sign up to see all 4 events
Funding: Series B through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/prosensa"><img src="https://indexed.vc/api/badge/company/prosensa" alt="Prosensa on Indexed.vc" width="260" height="76" /></a>